Pan Cancer T B.V.
Pan Cancer T is a biotechnology spin-out from Erasmus MC, Rotterdam, the Netherlands dedicated to discovering and developing T cell receptor (TCR) T cell therapies. The company exploits 20 years of pioneering research in the field of adoptive T cell therapies. This foundation serves as a springboard towards clinical testing of breakthrough therapies for solid tumors.
Pan Cancer T is a biotechnology spin-out from Erasmus MC, Rotterdam, the Netherlands dedicated to discovering and developing T cell receptor (TCR) T cell therapies. The company exploits 20 years of pioneering research in the field of adoptive T cell therapies. This foundation serves as a springboard towards clinical testing of breakthrough therapies for solid tumors.
Pan Cancer T develops natural affinity TCR T cell therapies towards unique and proprietary intracellular targets expressed by multiple solid tumors but not healthy tissues, and make T cell therapy maximally accessible despite tumor-microenvironment challenges.
Contact Pan Cancer T B.V.
Pancancer T BV Marconistraat 16 3029 AK Rotterdam